Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Mar 2;15(3):e0228601.
doi: 10.1371/journal.pone.0228601. eCollection 2020.

Zimbabwe's national third-line antiretroviral therapy program: Cohort description and treatment outcomes

Affiliations
Multicenter Study

Zimbabwe's national third-line antiretroviral therapy program: Cohort description and treatment outcomes

Cleophas Chimbetete et al. PLoS One. .

Abstract

Background: In 2015, Zimbabwe introduced third-line antiretroviral therapy (ART) through four designated treatment centers; three government clinics in Harare and Bulawayo, and Newlands Clinic (NC), operated by a private voluntary organization in Harare. We describe characteristics of patients receiving third line ART and analyzed treatment outcomes in this national programme as of 31 December 2018.

Methods: We described the population using proportions for categorical variables, and medians and interquartile ranges for continuous variables. Patients from NC, where data were more complete, were followed from the date of starting third-line ART until death, transfer, loss to follow up or 31 December 2018.

Results: A total of 209 patients had ever received third-line ART: 124 at NC and 85 from the three government clinics. HIV genotype results were available for 89 (72%) patients at NC and fourteen (16.5%) patients in the government clinics. Median duration of third line ART (years) in the government clinics was 2.3 (IQR:0.6-3.4), 1.3 (IQR: 0.7-1.7) and 1 (0.6-1.9). Of the 67 patients who received third line ART in the government clinics for at least six months, 53 (79%) had most recent viral load (VL) < 1000 copies/ml. Data on other treatment outcomes from government clinics were incomplete. From NC: a total of 109 (88%) patients were still in care, 13 (10.5%) had died and 2 (1.5%) were transferred. Median duration of third-line ART was 1.4 years (IQR: 0.6-2.8). Among the 111 NC patients who had received third-line ART for at least 6 months, 83 (75%) had a VL <50 copies/ml and 106 (95.5%) had a VL <1000 copies/ml.

Conclusion: Our findings demonstrate that, with comprehensive care, patients failing second-line ART can achieve high rates of virological suppression on third-line regimens. There is need to decentralize the provision of third-line ART in Zimbabwe. More needs to be done to improve completeness of data in the government clinics.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist

Figures

Fig 1
Fig 1. Patients commenced on third-line ART in Zimbabwe: 2015–2018.
Fig 2
Fig 2. Distribution of HIV drug resistance mutations at Newlands Clinic.

Similar articles

Cited by

References

    1. Estill J, Ford N, Salazar-Vizcaya L, Haas AD, Blaser N, Habiyambere V, et al. The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study. Lancet HIV. 2016;3: e132–e139. 10.1016/S2352-3018(16)00016-3 - DOI - PMC - PubMed
    1. Madec Y, Leroy S, Rey-Cuille M-A, Huber F, Calmy A. Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa—A Systematic Review and Meta-Analysis. Graham SM, editor. PLoS One. 2013;8: e82724 10.1371/journal.pone.0082724 - DOI - PMC - PubMed
    1. WHO | Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection WHO. World Health Organization; 2016; - PubMed
    1. National Medicine and Therapeutics Policy Advisory Committee; The AIDS and TB Directorate Ministry of Health and Child Care. Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe. 2013; 1–88. Available: https://www.google.ch/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUK...
    1. Lecher S, Williams J, Fonjungo PN, Kim AA, Ellenberger D, Zhang G, et al. Progress with scale-up of HIV viral load monitoring—seven Sub-Saharan African countries, January 2015–June 2016. Morbidity and Mortality Weekly Report. Department of Health and Human Services; 2016. pp. 1332–1335. 10.15585/mmwr.mm6547a2 - DOI - PubMed

Publication types

Substances